DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Wednesday.

Other equities analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. HC Wainwright restated a “buy” rating and issued a $68.00 price target (down from $74.00) on shares of DENTSPLY SIRONA in a research report on Monday. Credit Suisse Group restated an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Finally, Morgan Stanley upped their price target on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $66.25.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) traded down 1.21% during trading on Wednesday, reaching $53.11. 595,941 shares of the company’s stock were exchanged. The stock’s 50 day moving average price is $62.34 and its 200-day moving average price is $62.34. The stock’s market cap is $12.19 billion. DENTSPLY SIRONA has a 52-week low of $53.01 and a 52-week high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. The business had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.76 EPS. On average, equities research analysts forecast that DENTSPLY SIRONA will post $2.72 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-rating-lowered-to-strong-sell-at-bidaskclub/1495004.html.

Large investors have recently bought and sold shares of the stock. Commonwealth Bank of Australia raised its stake in DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 260 shares in the last quarter. Acrospire Investment Management LLC purchased a new stake in DENTSPLY SIRONA during the second quarter worth approximately $113,000. Dupont Capital Management Corp purchased a new stake in DENTSPLY SIRONA during the second quarter worth approximately $116,000. Korea Investment CORP raised its stake in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares in the last quarter. Finally, Sphera Funds Management LTD. purchased a new stake in DENTSPLY SIRONA during the second quarter worth approximately $162,000. 95.13% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.